Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential




Share Price Information for Summit Ther (SUMM)


Share Price: 21.25Bid: 20.50Ask: 22.00Change: 0.00 (0.00%)No Movement on Summit Ther
Spread: 1.50Spread as %: 7.32%Open: 22.00High: 0.00Low: 0.00Yesterday’s Close: 21.25

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
21.25
Share Price SpacerBid
20.50
Share Price SpacerAsk
22.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
104,977
Share Price SpacerOpen
22.00
Share Price SpacerHigh
0.00
Share Price SpacerLow
0.00
Share Price SpacerClose
21.25
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 160.49m £34.11m 3,000

52 Week High 200.00 52 Week High Date 26-JUN-2018
52 Week Low 17.00 52 Week Low Date 14-DEC-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
9 57,933 47,044 4.528 4.69 0.00 0.00


London South East Users info for Summit Ther




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

17-Jun-19
16:12:18
21.10
6,000
Sell* 
20.50
22.00
1,266
Trade Type:
Ordinary

17-Jun-19
15:42:51
21.10
815
Sell* 
20.50
22.00
171.97
Trade Type:
Ordinary

17-Jun-19
15:42:15
21.10
856
Sell* 
20.50
22.00
180.62
Trade Type:
Ordinary




View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
23-Apr-19Transfer From
Trade Notifier Information for Summit Therapeutics
Frank Armstrong held the position of Non-Executive Chairman at Summit Therapeutics at the time of this trade.
 Frank Armstrong
036,585158789
23-Apr-19Transfer From
Trade Notifier Information for Summit Therapeutics
Valerie Andrews held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Valerie Andrews
017,07366196
23-Apr-19Transfer From
Trade Notifier Information for Summit Therapeutics
David Wurzer held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 David Wurzer
017,07363196
View more Summit Ther directors dealings >>


PharmaGiles
Posts: 36
Opinion:No Opinion
Price:21.25
RE: The next RNS
Mon 17:43
Thanks Chris - look forward to hearing how it goes, and as you say they can't really give any substantial updates without an RNS... hopefully we'll start seeing a recovery soon..
Chrisatrdg
Posts: 1,523
Opinion:Strong Buy
Price:21.25
RE: The next RNS
Mon 17:38
Hi PharmaGiles - Yes I am going to the AGM this week & will feed back how it went but I am not expecting any news but it will be good to talk one to one & hear questions from other shareholders.
PharmaGiles
Posts: 36
Opinion:No Opinion
Price:21.25
RE: The next RNS
Mon 17:11
Hi Chris - are you by any chance going to the AGM? May (hopefully) be some new updates there? Unfortunately I can't attend..
Chrisatrdg
Posts: 1,523
Opinion:Strong Buy
Price:21.75
The next RNS
Mon 10:54
Could we be in for a surprise RNS soon in which it is announced that Summit will receive further funding for their C-Diff trials based on recent articles for the need to combat diseases like C-Diff there was a final realisation that their drug must succeed & so funds provided.Just a thought.
View more share chat for Summit Ther (SUMM) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.